Two distinct low-pH steps promote entry of vaccinia virus

Journal of Virology

Volumn 81, Issue 16, 2007, Pages 8613-8620

  Townsley, Alan C ^a   Moss, Bernard ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; ENDOSOME; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PH; PRIORITY JOURNAL; REPORTER GENE; VACCINIA VIRUS; VIRUS ACTIVATION; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

ACIDS; CELL LINE; CELL MEMBRANE; ENDOSOMES; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE FUSION; MODELS, BIOLOGICAL; PEPTIDE HYDROLASES; VACCINIA VIRUS; VIRION; VIRUS INTERNALIZATION;

VACCINIA VIRUS;

EID: 34547823441     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00606-07     Document Type: Article

References (37)

1. Anderson, B. M., and E. C. Vasini. 1970. Nonpolar effects in reactions of the sulfhydryl group of papain. Biochemistry 9:3348-3352.
2. Armstrong, J. A., D. H. Metz, and M. R. Young. 1973. The mode of entry of vaccinia virus into L cells. J. Gen. Virol. 21:533-537.
3. Bron, R., J. M. Wahlberg, H. Garoff, and J. Wilschut. 1993. Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein. EMBO J. 12:693-701.
4. Brown, E., T. G. Senkevich, and B. Moss. 2006. Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related 11 protein. J. Virol. 80:9455-9464.
5. Carter, G. C., M. Law, M. Hollinshead, and G. L. Smith. 2005. Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J. Gen. Virol. 86:1279-1290.
6. Chang, A., and D. H. Metz. 1976. Further investigations on the mode of entry of vaccinia virus into cells. J. Gen. Virol. 32:275-282.
7. Chung, C.-S., J.-C. Hsiao, Y.-S. Chang, and W. Chang. 1998. A27L protein mediates vaccinia virus interaction with cell surface heparin sulfate. J. Virol. 72:1577-1585.
8. Corver, J., A. Ortiz, S. L. Allison, J. Schalich, F. X. Heinz, and J. Wilschut. 2000. Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology 269:37-46.
9. Di Simone, C., and M. J. Buchmeier. 1995. Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex. Virology 209:3-9.
10. Earl, P. L., N. Cooper, S. Wyatt, B. Moss, and M. W. Carroll. 1998. Preparation of cell cultures and vaccinia virus stocks, p. 16.16.1-16.16.3. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. John Wiley and Sons, New York, NY.
11. Earp, L. J., S. E. Delos, H. E. Park, and J. M. White. 2005. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 285:25-66.
12. Hsiao, J.-C., C.-S. Chung, and W. Chang. 1999. Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J. Virol. 73:8750-8761.
13. Ichihashi, Y., and M. Oie. 1980. Adsorption and penetration of the trypsinized vaccinia virion. Virology 101:50-60.
14. Ichihashi, Y., and M. Oie. 1982. Proteolytic activation of vaccinia virus for penetration phase of infection. Virology 116:297-305.
15. Ichihashi, Y., T. Tsuruhara, and M. Oie. 1982. The effect of proteolytic enzymes on the infectivity of vaccinia virus. Virology 122:279-289.
16. Izmailyan, R. A., C.-Y. Huang, S. Mohammad, S. N. Isaacs, and W. Chang. 2006. The envelope G3L protein is essential for entry of vaccinia virus into host cells. J. Virol. 80:8402-8410.
17. Joklik, W. K. 1962. The purification of four strains of poxvirus. Virology 18:9-18.
18. Korte, T., K. Ludwig, F. P. Booy, R. Blumenthal, and A. Herrmann. 1999. Conformational intermediates and fusion activity of influenza virus hemagglutinin. J. Virol. 73:4567-4574.
19. Law, M., G. C. Carter, K. L. Roberts, M. Hollinshead, and G. L. Smith. 2006. Ligand-induced and non-fusogenic dissolution of a viral membrane. Proc. Natl. Acad. Sci. USA 103:5989-5994.
20. Lin, C.-L., C.-S. Chung, H. G. Heine, and W. Chang. 2000. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J. Virol. 74:3353-3365.
21. Milne, R. S., A. V. Nicola, J. C. Whitbeck, R. J. Eisenberg, and G. H. Cohen. 2005. Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1. J. Virol. 79:6655-6663.
22. Moss, B. 2007. Poxviridae: the viruses and their replication, p. 2905-2946. In D. M. Knipe (ed.), Fields virology, vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
23. Moss, B. 2006. Poxvirus entry and membrane fusion. Virology 344:48-54.
24. Nicola, A. V., A. M. McEvoy, and S. E. Straus. 2003. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J. Virol. 77:5324-5332.
25. Nir, S., N. Duzgunes, M. C. de Lima, and D. Hoekstra. 1990. Fusion of enveloped viruses with cells and liposomes. Activity and inactivation. Cell Biophys. 17:181-201.
26. Ojeda, S., T. G. Senkevich, and B. Moss. 2006. Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene. J. Virol. 80:51-61.
27. Planterose, N. D., C. Nishimura, and N. P. Salzman. 1962. The purification of vaccinia virus from cell cultures. Virology 18:294-301.
28. Puri, A., J. Winick, R. J. Lowy, D. Covell, O. Eidelman, A. Walter, and R. Blumenthal. 1988. Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH. J. Biol. Chem. 263:4749-4753.
29. Senkevich, T. G., and B. Moss. 2005. Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion. J. Virol. 79:4744-4754.
30. Senkevich, T. G., S. Ojeda, A. Townsley, G. E. Nelson, and B. Moss. 2005. Poxvirus multiprotein entry-fusion complex. Proc. Natl. Acad. Sci. USA 102:18572-18577.
31. Senkevich, T. G., B. M. Ward, and B. Moss. 2004. Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene. J. Virol. 78:2357-2366.
32. Smith, G. L., and M. Law. 2004. The exit of vaccinia virus from infected cells. Virus Res. 106:189-197.
33. Stegmann, T., I. Bartoldus, and J. Zumbrunn. 1995. Influenza hemagglutinin-mediated membrane fusion: influence of receptor binding on the lag phase preceding fusion. Biochemistry 34:1825-1832.
34. Townsley, A., T. G. Senkevich, and B. Moss. 2005. The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion. J. Virol. 79:10988-10998.
35. Townsley, A., T. G. Senkevich, and B. Moss. 2005. Vaccinia virus A21 virion membrane protein is required for cell entry and fusion. J. Virol. 79:9458-9469.
36. Townsley, A. C., A. S. Weisberg, T. R. Wagenaar, and B. Moss. 2006. Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. J. Virol. 80:8899-8908.
37. Wagenaar, T. R., and B. Moss. 2007. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J. Virol. 81:6286-6293.